255 related articles for article (PubMed ID: 12871671)
1. The glucagon-like peptides: a double-edged therapeutic sword?
Perry T; Greig NH
Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
[No Abstract] [Full Text] [Related]
2. [Glucagon-like peptide-1 (GLP-1) receptor].
Taminato T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():535-41. PubMed ID: 12238094
[No Abstract] [Full Text] [Related]
3. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
4. The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists.
Al-Sabah S; Donnelly D
Protein Pept Lett; 2004 Feb; 11(1):9-14. PubMed ID: 14965273
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptides.
Drucker DJ
Diabetes; 1998 Feb; 47(2):159-69. PubMed ID: 9519708
[TBL] [Abstract][Full Text] [Related]
6. A gut feeling.
Pronsati MP
Adv Nurse Pract; 2004 Aug; 12(8):8. PubMed ID: 15354498
[No Abstract] [Full Text] [Related]
7. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
Gefel D; Barg Y; Zimlichman R
Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
[TBL] [Abstract][Full Text] [Related]
8. Central glucagon-like peptide-I in the control of feeding.
Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR
Biochem Soc Trans; 1996 May; 24(2):581-4. PubMed ID: 8736807
[No Abstract] [Full Text] [Related]
9. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
Wettergren A
Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
[No Abstract] [Full Text] [Related]
10. The human glucagon-like peptide-1 (GLP-1) receptor. Cloning and functional expression.
Dillon JS; Wheeler MB; Leng XH; Ligon BB; Boyd AE
Adv Exp Med Biol; 1997; 426():113-9. PubMed ID: 9544263
[No Abstract] [Full Text] [Related]
11. Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues.
López de Maturana R; Treece-Birch J; Abidi F; Findlay JB; Donnelly D
Protein Pept Lett; 2004 Feb; 11(1):15-22. PubMed ID: 14965274
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
13. ["Glucagon-like peptide I": a therapeutic alternative for diabetes mellitus?].
Fehmann HC; Göke B
Dtsch Med Wochenschr; 1994 Feb; 119(8):275-9. PubMed ID: 8112212
[No Abstract] [Full Text] [Related]
14. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.
Perry T; Lahiri DK; Chen D; Zhou J; Shaw KT; Egan JM; Greig NH
J Pharmacol Exp Ther; 2002 Mar; 300(3):958-66. PubMed ID: 11861804
[TBL] [Abstract][Full Text] [Related]
15. Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.
Holz GG; Habener JF
Comp Biochem Physiol B Biochem Mol Biol; 1998 Oct; 121(2):177-84. PubMed ID: 9972293
[TBL] [Abstract][Full Text] [Related]
16. [GLP-1 and the control of insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 1994; ():33-46. PubMed ID: 8051830
[No Abstract] [Full Text] [Related]
17. [Incretin research in the development of new strategies of diabetes therapy].
Göke B; Göke R; Fehmann HC; Arnold R
Internist (Berl); 1995 Apr; 36(4):343-9. PubMed ID: 7775082
[No Abstract] [Full Text] [Related]
18. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
[No Abstract] [Full Text] [Related]
19. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.
Holz GG; Chepurny OG
Curr Med Chem; 2003 Nov; 10(22):2471-83. PubMed ID: 14529486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
